THE COST-EFFECTIVENESS OF TEMOZOLOMIDE IN THE ADJUVANT TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA IN THE UNITED STATES

被引：0
|
作者：
Messali, A. [1 ]
Hay, J. [1 ]
Villacorta, R. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A221 / A222
页数：2
相关论文
共 50 条
  • [31] The use of temozolomide as a radiosensitiser for the treatment of newly diagnosed glioblastoma multiforme
    Walsh, N.
    Fleet, A.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2007, 6 (02) : 103 - 110
  • [32] Cost-effectiveness of HIV testing and treatment in the United States
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Weinstein, Milton C.
    Paltiel, A. David
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S248 - S254
  • [33] Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme - A report from the EORTC 26981/22981 NCI-C CE3 intergroup study
    Lamers, Leida M.
    Stupp, Roger
    van den Bent, Martin J.
    Al, Maiwenn J.
    Gorlia, Thierry
    Wasserfallen, Jean-Blaise
    Mittmann, Nicole
    Seung, Soo Jin
    Crott, Ralph
    Groot, Carin A. Uyl-de
    CANCER, 2008, 112 (06) : 1337 - 1344
  • [34] COST-EFFECTIVENESS ANALYSIS OF TUMOR TREATING FIELDS IN THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA BASED ON REAL-WORLD DATA
    Xiang, Y.
    Xu, Z.
    Zhou, S.
    Liu, S.
    Chen, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S76 - S76
  • [35] Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study
    Chen, Jie
    Wang, Tingting
    Liu, Wanming
    Qiu, Hui
    Zhang, Nie
    Chen, Xueting
    Ding, Xin
    Zhang, Longzhen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States
    Zhang, Shujing
    Bensimon, Arielle G.
    Xu, Ruifeng
    Jiang, Ruixuan
    Greatsinger, Alexandra
    Zhang, Adina
    Fukunaga-Kalabis, Mizuho
    Krepler, Clemens
    ADVANCES IN THERAPY, 2023, 40 (07) : 3038 - 3055
  • [37] Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study
    Nicholas, M. K.
    Lucas, R. V.
    Arzbaecher, J.
    Paleologos, N.
    Krouwer, H.
    Malkin, M.
    Omar, A.
    Vick, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
    Mathen, Peter
    Rowe, Lindsay
    Mackey, Megan
    Smart, DeeDee
    Tofilon, Philip
    Camphausen, Kevin
    NEURO-ONCOLOGY PRACTICE, 2020, 7 (03) : 268 - 276
  • [39] Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States
    Shujing Zhang
    Arielle G. Bensimon
    Ruifeng Xu
    Ruixuan Jiang
    Alexandra Greatsinger
    Adina Zhang
    Mizuho Fukunaga-Kalabis
    Clemens Krepler
    Advances in Therapy, 2023, 40 : 3038 - 3055
  • [40] The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates
    Grosse, Scott D.
    Palomaki, Glenn E.
    Mvundura, Mercy
    Hampel, Heather
    GENETICS IN MEDICINE, 2015, 17 (06) : 510 - 511
12345